Protalix BioTherapeutics, Inc.
Overview
Protalix BioTherapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins. The company uses its proprietary ProCellEx® plant cell-based protein expression system to develop products for the treatment of rare diseases. Protalix aims to improve patient outcomes with innovative therapies.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Protalix BioTherapeutics, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.